A CV-TMLE global test approach to improve power in rare disease clinical studies with multiple-component endpoints

Tianyue Zhou, Susan Gruber, Hana Lee +3

Rare disease trials face unique statistical challenges due to limited patient populations and heterogeneous clinical manifestations among patients. Multiple endpoints are often nec…